ADMA Biologics Announces Successful Completion of FDA Pre-Approval Manufacturing Facility Inspection
ADMA Biologics, Inc. (NASDAQ:ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced the United